Atria Wealth Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$10.1M Sell
12,987
-25,286
-66% -$19.6M 0.23% 99
2025
Q1
$31.6M Sell
38,273
-24
-0.1% -$20K 0.38% 46
2024
Q4
$29.6M Sell
38,297
-4,211
-10% -$3.49M 0.32% 60
2024
Q3
$37.7M Sell
42,508
-857
-2% -$770K 0.41% 43
2024
Q2
$39.3M Buy
43,365
+63
+0.1% +$50.4K 0.43% 35
2024
Q1
$33.7M Sell
43,302
-991
-2% -$705K 0.38% 43
2023
Q4
$25.8M Buy
44,293
+2,171
+5% +$1.27M 0.32% 59
2023
Q3
$22.6M Buy
42,122
+3,452
+9% +$1.78M 0.32% 64
2023
Q2
$18.1M Buy
38,670
+4,204
+12% +$1.76M 0.25% 89
2023
Q1
$11.8M Buy
34,466
+1,687
+5% +$569K 0.18% 128
2022
Q4
$12M Buy
32,779
+566
+2% +$201K 0.19% 121
2022
Q3
$10.4M Buy
32,213
+8,182
+34% +$2.59M 0.18% 120
2022
Q2
$7.79M Sell
24,031
-5,160
-18% -$1.55M 0.15% 149
2022
Q1
$8.36M Buy
+29,191
New +$7.51M 0.14% 154

Other funds holding LLY

Atria Wealth Solutions's LLY Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Eli Lilly (LLY) stake by 66% in Q2 2025, selling an estimated $19.6M and leaving 12,987 shares worth $10.1M. The position accounts for 0.23% of the portfolio, ranked #99.

Atria Wealth Solutions first reported a position in LLY in Q1 2022 and has held it in 14 quarters since. The position peaked at $39.3M in Q2 2024. 3,914 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Atria Wealth Solutions held 12,987 shares of Eli Lilly worth $10.1M as of Q2 2025.
  • Atria Wealth Solutions sold 25,286 Eli Lilly shares in Q2 2025, an estimated $19.6M.
  • Eli Lilly made up 0.23% of Atria Wealth Solutions's portfolio in Q2 2025, its #99 holding.
  • Atria Wealth Solutions first reported a position in Eli Lilly in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Eli Lilly position peaked at $39.3M in Q2 2024.
  • 3,914 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.